Sanofi Ups 2025 Sales Guidance to High Single Digits At CER, From Mid-to-High Range; Plans To Complete €5B Share Buyback In 2025; 80.3% Already Repurchased
Benzinga
07-31
Guidance
In 2025, sales are anticipated to grow by a high single-digit percentage at CER (previously mid-to-high single-digit). Sanofi confirms the expectation of a strong business EPS rebound with growth at a low double-digit percentage at CER (before share buyback), now including all expenses from newly acquired businesses4
Sanofi intends to complete its €5 billion share buyback program in 2025. 80.3% has been repurchased to date